1 Min Read
Feb 7 (Reuters) - RXI Pharmaceuticals Corp -
* RXI Pharmaceuticals appoints leading oncology expert, Rolf Kiessling, to scientific advisory board Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.